Advertisement
Canada markets close in 1 hour 19 minutes
  • S&P/TSX

    21,977.08
    +91.70 (+0.42%)
     
  • S&P 500

    5,106.00
    +57.58 (+1.14%)
     
  • DOW

    38,289.64
    +203.84 (+0.54%)
     
  • CAD/USD

    0.7319
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    83.70
    +0.13 (+0.16%)
     
  • Bitcoin CAD

    87,540.50
    -632.95 (-0.72%)
     
  • CMC Crypto 200

    1,332.69
    -63.84 (-4.41%)
     
  • GOLD FUTURES

    2,351.80
    +9.30 (+0.40%)
     
  • RUSSELL 2000

    2,002.79
    +21.68 (+1.09%)
     
  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     
  • NASDAQ

    15,929.36
    +317.60 (+2.03%)
     
  • VOLATILITY

    15.10
    -0.27 (-1.76%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     

Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

Bristol Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) compete against each other in the marketplace every day. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the prospects for this experimental drug. Keith Speights: Bristol Myers Squibb and Johnson & Johnson compete head-to-head in the blood thinner market.